Riskpilot← Back to searchSign inGet full accessNORGINE NORGE AS
ASActiveOrg 990048037Filipstad Brygge 1, 0252 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 20065 employeeswww.norgine.no
Revenue 2024
NOK 15,8M
+58% vs 2023
EBITDA margin
4.8%
+99% vs 2023
Equity ratio
52.8%
Financial strength
Net profit 2024
NOK 719K
+91% vs 2023
| Revenue | NOK 15,8M | +58% |
| EBITDA | NOK 753K | +99% |
| Net profit | NOK 719K | +91% |
| Total assets | NOK 18,7M | +21% |
| Equity | NOK 9,9M | +8% |
| Employees | 5 | — |
Legal name
NORGINE NORGE AS
Org number
990048037
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. august 2006
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Salg og markedsføring av medisinske produkter og dertil knyttede aktiviteter.
Address
Filipstad Brygge 1, 0252 Oslo
Phone
+4722422800
Email
norge@norgine.com
Website
www.norgine.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 11 753 | 8 633 | 15 279 | 10 007 | 15 828 |
| Staff expenses | −3 458 | −4 414 | −5 988 | −6 193 | −0 |
| EBITDA | 3 566 | 74 | 1 231 | 379 | 753 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 3 566 | 74 | 1 231 | 379 | 753 |
| Net financials | 72 | −151 | −8 | −24 | 472 |
| Profit before tax | 3 638 | −77 | 1 223 | 355 | 1 225 |
| Tax | −0 | −0 | 28 | −22 | −0 |
| Net profit | 3 638 | −77 | 1 195 | 377 | 719 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 14 766 | 12 974 | 18 101 | 15 508 | 18 714 |
| Equity | 7 683 | 7 606 | 8 782 | 9 159 | 9 878 |
| Long-term debt | 4 244 | 4 244 | 4 244 | 0 | 4 244 |
| Short-term debt | 2 838 | 1 124 | 5 075 | 2 105 | 4 591 |
| Total debt | 7 083 | 5 368 | 9 319 | 2 105 | 8 836 |
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
20202024
Equity ratio
52.8%
This company
38.2%
Market median
+38% vs market
20202024
Return on equity
7.3%
This company
18.4%
Market median
-60% vs market
20202024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20202024
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20202024
Debt / equity
0.89×
This company
0.62×
Market median
+44% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Board of Directors | 2023 | |
| Former (7) | ||
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Chairman | 2019 – 2021 | |
| Board of Directors | 2019 – 2021 | |
| Chairman | 2022 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Chairman | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Norgine B.V. | Company | 100% | 100% | 2024 |
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORGINE NORGE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marie Sophie Romann | Board of Directors | 0 companies |
| Erik Niklas Eriksson | Chairman | 0 companies |
| Ina Høydal Helle | Board of Directors | 0 companies |
| Jeremy John Cuffe | Board of Directors | 0 companies |
| Paul John Ruelle | Chairman | 0 companies |
| Tara Bussey | Board of Directors | 0 companies |
| Kenneth Andrew Macritchie | Chairman | 0 companies |
| Kenneth Eric Scrimgeour | Board of Directors | 0 companies |
| Laura Elizabeth Barrell | Board of Directors | 0 companies |
| Michael Lange | Chairman | 0 companies |